Filing Details
- Accession Number:
- 0001181431-12-050842
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-17 17:56:39
- Reporting Period:
- 2012-09-17
- Filing Date:
- 2012-09-17
- Accepted Time:
- 2012-09-17 17:56:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 919745 | Dara Biosciences Inc. | DARA | Pharmaceutical Preparations (2834) | 043216862 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1428764 | David Drutz | C/O Dara Biosciences, Inc. 8601 Six Forks Road, Suite 160 Raleigh NC 27615 | Ceo And Cmo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-09-17 | 25,000 | $1.06 | 78,073 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.02 to $1.08, inclusive. The reporting person undertakes to provide DARA Biosciences, Inc., any security holder of DARA Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Billionaire Hedge Funds
